New checklists for network meta-analysis, modelling and observational studies

Although they are termed ‘questionnaires’ within their associated articles, they are in effect Drummond-like checklists.  Widely used checklists already exist for modelling and observational studies (although improvement is always possible), therefore, the need for a network meta-analysis checklist is perhaps greatest.

So why have they been produced?   They were developed by the Academy of Managed Care Pharmacy(AMCP), the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and the National Pharmaceutical Council (NPC), primarily for formulary decisions.  However, they clearly have relevance across economics, evidence synthesis and HTA.

A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report. Berger, Martin, Husereau, Worley, Allen, Yang, Quon, Mullins, Kahler, Crown

Indirect Treatment Comparison/Network Meta-Analysis Study Questionnaire to Assess Relevance and Credibility to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report.  Jansen, Trikalinos, Cappelleri, Daw, Andes, Eldessouki, Salanti

Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report.  Caro, Eddy, Kan, Kaltz, Patel, Eldessouki, Briggs

The articles were published in the March/April issue (Vol.17 Iss.2) of Value in Health.